Can exercise help cancer patients? new study aims to find out

NCT ID NCT06960291

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a supervised exercise program for people with cancer. Participants will take part in group exercise classes twice a week for 8 to 12 weeks. The goal is to see if the program helps improve physical activity levels and manage cancer-related symptoms. The study will include 740 adults across Canada.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
supervised group exercise classes (aerobic, resistance, balance, flexibility)
What this could lead to
If successful, this could provide a proven, community-based exercise program to help cancer patients feel better and stay active during and after treatment.
What could go wrong
This is an implementation study, not a test of a new drug. Benefits may vary, and the program may not be available everywhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre hospitalier de l'Université de Montréal

    RECRUITING

    Montreal, Quebec, H2X 0A9, Canada

  • Nova Scotia Health Authority

    RECRUITING

    Halifax, Nova Scotia, B3H 4R2, Canada

    Contact Email: •••••@•••••

  • University of British Columbia

    RECRUITING

    Vancouver, British Columbia, V6T 1Z7, Canada

  • University of Calgary

    RECRUITING

    Calgary, Alberta, T2N1N4, Canada

  • University of Toronto

    RECRUITING

    Toronto, Ontario, M5S 1A1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.